Phase II trial of pentostatin, cyclophosphamide, and rituximab followed by consolidation with lenalidomide for previously untreated B-chronic lymphocytic leukaemia or small lymphocytic lymphoma.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2017
At a glance
- Drugs Lenalidomide (Primary) ; Cyclophosphamide; Pentostatin; Rituximab
- Indications Chronic lymphocytic leukaemia; Lymphoma
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 19 Apr 2016 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016.